加拿大马尼托巴省药剂师对药物基因组学的知识和看法
Abdullah Al Maruf1,2,3,4, Meagan Shields5, Amber Fryza1
1College of Pharmacy, University of Manitoba, Winnipeg, MB, R3E 0T5, Canada.
Pharmacogenomics
|March 20, 2024
概括
马尼托巴省的药剂师对药物基因组学 (PGx) 有积极的看法,但缺乏足够的知识和培训. 大多数人希望获得更多的教育,将PGx整合到他们的实践中,以提高药物的有效性和安全性.
科学领域:
- 药物基因组学 药物基因组学
- 临床药房 临床药房
- 药物管理 药物管理
背景情况:
- 药物基因组学 (PGx) 提供了个性化医学的潜力.
- 了解药剂师的知识对于PGx实施至关重要.
研究的目的:
- 评估加拿大马尼托巴省药剂师的药物基因组学知识和看法.
- 确定将PGx纳入临床实践的障碍和促进因素.
主要方法:
- 在曼尼托巴省向药剂师进行了一项基于网络的40项调查.
- 从74名参与的药剂师收集了数据.
主要成果:
- 三分之一的药剂师有一些PGx教育;只有12.2%使用PGx测试结果.
- 据报道,对PGx测试和资源的自我评价知识较低.
- 大多数药剂师认为PGx提高了疗效 (82.4%),并防止了药物不良反应 (81.1%),其中91%的人希望获得更多的教育.
结论:
- 曼尼托巴省的药剂师对药物基因组学有着有利的看法.
- 目前对PGx实施的准备程度较低,这凸显了需要加强教育和培训计划的需要.
相关概念视频
Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
Pharmacokinetic Models: Overview
673
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
673
Pharmacokinetics: Overview
6.3K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
6.3K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Drug Distribution: Plasma Protein Binding
5.6K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.6K


